万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
A synthetic peptide from the internal region of MEK1 which includes the mutation of F53L, human origin.
- 亚型:
lgG
- 形态:
液体
- 保存条件:
-20℃
- 克隆性:
单克隆
- 标记物:
FITC
- 适应物种:
脊椎动物
- 保质期:
24个月
- 抗原来源:
蛋白
- 目录编号:
TD-26263
- 级别:
科研级
- 库存:
999
- 供应商:
武汉天德
- 宿主:
Mouse
- 应用范围:
ELISA, WB, IHC
- 浓度:
1mg/ml
- 靶点:
F53L
- 抗体英文名:
Anti MEK1(F53L) Mouse Monoclonal Antibody
- 抗体名:
MEK1(F53L)
- 规格:
100 μL
MEK1(F53L)
| Cat. #: TD-26263 |
| Gene Symbol: MAP2K1; MAPKK1; MEK1; MKK1; PRKMK1 |
| Description: Anti-MEK1(F53L) Mouse Monoclonal Antibody |
| Background: MEK1 (also known as extracellular signal-regulated kinases, ERKs) plays important role in the MAP kinase cascade, which transduces multiple extracellular signals to control cell growth, proliferation and differentiation. Activated upon growth factors stimulation, MEK1 phosphorylates MAPK3/ERK1 and MAPK1/ERK2, thus activates the MAP pathway and regulates transcription. Abnormal of the MEK1 protein, including point mutations, are implicated in diseases such as cardiofaciocutaneous syndrome (CFC) and melanoma. |
| Immunogen: A synthetic peptide from the internal region of MEK1 which includes the mutation of F53L, human origin. |
| Applications: ELISA, WB, IHC |
| Recommended Dilutions: ELISA: 1:1000-1:2000 WB: 1:500-1:1000 IHC: 1:50-1:100 |
| Concentration: 1 mg/ml |
| Host Species: Mouse |
| Format: Liquid |
| Clonality: Monoclonal |
| Isotype: IgG |
| Purity: Purified from ascites |
| Preservative: No |
| Constituents: PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 50% glycerol |
| Species Reactivity: Recognizes F53L mutant, but not wild type MEK1 of vertebrates. |
| Storage Conditions: Store at -20°C. Avoid repeated freezing and thawing |
Western blot:
Immunofluorescence:
|
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Recent studies have shown that the meiosis-specific kinase, Mek1, plays a key role in promoting recombination between homologous chromosomes during meiosis in budding yeast by suppressing recombination between sister chromatids
砷剂疗法的前世今生:「吃最毒的药,治最难的病」,「砒霜」抗癌再登 Cell 子刊
Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): I. As2O3 Exerts Dose-Dependent Dual Effects on APL Cells, Blood, 1997.[7] G.-Q. C. J.-H. N. X.-S. L. S.-M. X. Q.-Y. Q. J. Z. W. T. G.-L. S. K.-Q. Y. Y. C. L. Z. Z.-W. F. Y.-T. W. J. M
Science:直击肿瘤命门,Shibin Zhou 等开发靶向 TP53 突变的双特异性抗体
,Rosenberg 团队就在 JCI 发表了一项 TP53 新抗原相关的研究 [3]。 图片来源:The Journal of clinical investigation 研究人员对 140 例上皮肿瘤患者中的 TP53 突变情况进行了检测,结果发现, 65%(91/140)携带 TP53 突变,其中 36%(33/140)含有 TP53 常见突变。研究对 COSMIC 数据库显示的所有肿瘤类型中最常见的 12 种 TP53 突变:R175H, Y220C, G245S, G245D, R248L, R248
技术资料暂无技术资料 索取技术资料











